Parisa Shabani

451 total citations
23 papers, 279 citations indexed

About

Parisa Shabani is a scholar working on Epidemiology, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, Parisa Shabani has authored 23 papers receiving a total of 279 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 8 papers in Cardiology and Cardiovascular Medicine and 6 papers in Molecular Biology. Recurrent topics in Parisa Shabani's work include Liver Disease Diagnosis and Treatment (6 papers), Adipose Tissue and Metabolism (4 papers) and Adipokines, Inflammation, and Metabolic Diseases (4 papers). Parisa Shabani is often cited by papers focused on Liver Disease Diagnosis and Treatment (6 papers), Adipose Tissue and Metabolism (4 papers) and Adipokines, Inflammation, and Metabolic Diseases (4 papers). Parisa Shabani collaborates with scholars based in Iran, United States and Australia. Parisa Shabani's co-authors include Mahmood Doosti, Solaleh Emamgholipour, Hossein Poustchi, Mehrnoosh Shanaki, Nariman Moradi, Reza Fadaei, Sara Karami, Fatemeh Yari, Akram Vatannejad and Davood Bashash and has published in prestigious journals such as PLoS ONE, Biochemical and Biophysical Research Communications and Cardiovascular Research.

In The Last Decade

Parisa Shabani

23 papers receiving 275 citations

Peers

Countries citing papers authored by Parisa Shabani

Since Specialization

Citations

This map shows the geographic impact of Parisa Shabani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Parisa Shabani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Parisa Shabani more than expected).

Fields of papers citing papers by Parisa Shabani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Parisa Shabani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Parisa Shabani. The network helps show where Parisa Shabani may publish in the future.

Co-authorship network of co-authors of Parisa Shabani

This figure shows the co-authorship network connecting the top 25 collaborators of Parisa Shabani. A scholar is included among the top collaborators of Parisa Shabani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Parisa Shabani. Parisa Shabani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Bone marrow cells contribute to seven different endothelial cell populations in the heart 2024 ·Basic Research in Cardiology ·Parisa Shabani, Vahagn Ohanyan, (unknown), (unknown), (unknown), Liya Yin, Christopher Kolz, (unknown), Molly Enrick, Ping Zhang, (unknown), William M. Chilian	3
2	Anti-inflammatory function of apolipoprotein B-depleted plasma is impaired in non-alcoholic fatty liver disease 2022 ·PLoS ONE ·(unknown), Hossein Poustchi, Fatemeh Yari, Amir Reza Radmard, Sara Karami, (unknown), Parisa Shabani, Ali Khaleghian	5
3	Circulating levels of FAM19A5 are inversely associated with subclinical atherosclerosis in non-alcoholic fatty liver disease 2021 ·BMC Endocrine Disorders ·Fatemeh Yari, Parisa Shabani, Sara Karami, (unknown), Hossein Poustchi, Ahmad Reza Bandegi	8
4	Association of anti-oxidative capacity of HDL with subclinical atherosclerosis in subjects with and without non-alcoholic fatty liver disease 2021 ·Diabetology & Metabolic Syndrome ·Sara Karami, Hossein Poustchi, (unknown), Amir Reza Radmard, Fatemeh Yari, (unknown), Parisa Shabani	28
5	Prospective Isolation of ISL1+ Cardiac Progenitors from Human ESCs for Myocardial Infarction Therapy 2021 ·Stem Cell Reports ·Zaniar Ghazizadeh, Faranak Fattahi, Mehdi Mirzaei, (unknown), Jaesuk Lee, Sehyun Chae, Daehee Hwang, Kyunghee Byun, Mehdi Sharifi Tabar, Sara Taleahmad, Shahab Mirshahvaladi, Parisa Shabani, Hananeh Fonoudi, Paul A. Haynes, Hossein Baharvand, Nasser Aghdami, T.E. Evans, Bong‐Hee Lee, Ghasem Hosseini Salekdeh	1
6	The C1q/TNF-related proteins (CTRPs) in pathogenesis of obesity-related metabolic disorders: Focus on type 2 diabetes and cardiovascular diseases 2020 ·Life Sciences ·Mehrnoosh Shanaki, Parisa Shabani, Afsaneh Goudarzi, (unknown), Davood Bashash, Solaleh Emamgholipour	28
7	Association between HDACs and pro-inflammatory cytokine gene expressions in obesity 2020 ·Archives of Physiology and Biochemistry ·Mehrnoosh Shanaki, (unknown), Parisa Shabani, (unknown)	14
8	Cardioprotective effects of omega‐3 fatty acids and ascorbic acid improve regenerative capacity of embryonic stem cell‐derived cardiac lineage cells 2019 ·BioFactors ·Parisa Shabani, Zaniar Ghazizadeh, Sattar Gorgani‐Firuzjaee, (unknown), Sarah Rajabi, Sadaf Vahdat, Yaser Azizi, Mahmood Doosti, Nasser Aghdami, Hossein Baharvand	13
9	Prospective Isolation of ISL1+ Cardiac Progenitors from Human ESCs for Myocardial Infarction Therapy 2018 ·Stem Cell Reports ·Zaniar Ghazizadeh, Faranak Fattahi, Mehdi Mirzaei, (unknown), Jaesuk Lee, Sehyun Chae, Daehee Hwang, Kyunghee Byun, Mehdi Sharifi Tabar, Sara Taleahmad, Shahab Mirshahvaladi, Parisa Shabani, Hananeh Fonoudi, Paul A. Haynes, Hossein Baharvand, Nasser Aghdami, Todd Evans, Bong‐Hee Lee, Ghasem Hosseini Salekdeh	15
10	Lower circulating levels of CTRP12 and CTRP13 in polycystic ovarian syndrome: Irrespective of obesity 2018 ·PLoS ONE ·Mehrnoosh Shanaki, Nariman Moradi, Reza Fadaei, Zahra Zandieh, Parisa Shabani, Akram Vatannejad	25
11	CTRP1 in Liver Disease 2016 ·Advances in clinical chemistry ·Parisa Shabani, Solaleh Emamgholipour, Mahmood Doosti	19
12	The association between bone turnover markers and microvascular complications of type 2 diabetes 2016 ·Journal of Diabetes & Metabolic Disorders ·Zhila Maghbooli, Parisa Shabani, Sattar Gorgani‐Firuzjaee, Arash Hossein‐Nezhad	15
13	Circulating Levels of LAMP2 in Coronary Artery Disease: Association with Serum Lipid Profile 2016 ·Hormone and Metabolic Research ·Maryam Teimouri, Parisa Shabani, Fatemeh Zali, Mahdi Najafi, (unknown), (unknown), Akram Vatannejad, Mahmood Doosti	4
14	Exogenous treatment with eicosapentaenoic acid supports maturation of cardiomyocytes derived from embryonic stem cells 2015 ·Biochemical and Biophysical Research Communications ·Parisa Shabani, Zaniar Ghazizadeh, Sara Pahlavan, (unknown), Hossein Baharvand, Nasser Aghdami, Mahmood Doosti	8
15	Circulating Level of CTRP1 in Patients with Nonalcoholic Fatty Liver Disease (NAFLD): Is It through Insulin Resistance? 2015 ·PLoS ONE ·Parisa Shabani, (unknown), (unknown), Solaleh Emamgholipour, (unknown), Hossein Poustchi, Mahmood Doosti	30
16	The association of circulating levels of complement-C1q TNF-related protein 5 (CTRP5) with nonalcoholic fatty liver disease and type 2 diabetes: a case–control study 2015 ·Diabetology & Metabolic Syndrome ·Solaleh Emamgholipour, Nariman Moradi, (unknown), Parisa Shabani, Reza Fadaei, Hossein Poustchi, Mahmood Doosti	26
17	Estradiol supplementation during the luteal phase in poor responder patients undergoing in vitro fertilization: a randomized clinical trial 2011 ·Journal of Assisted Reproduction and Genetics ·Marzieh Aghahosseini, (unknown), Sepideh Khodaverdi, Fatemeh Esfahani, (unknown), (unknown), Ali Kord Valeshabad, Atossa Mahdavi, Parvin Fallahi, Parisa Shabani, (unknown), (unknown)	15
18	THE EFFECT OF METFORMIN ON UTEROPLACENTAL CIRCULATION AND PREGNANCY OUTCOMES IN PREGNANT WOMEN WITH POLYCYSTIC OVARY SYNDROME 2010 ·Tehran University Medical Journal TUMS Publications ·(unknown), Ashraf Aleyasin, Parisa Shabani, Sepideh Khodaverdi, (unknown)	1
19	Association of VDR gene polymorphism with insulin resistance in diabetic patients 2009 ·Journal of Diabetes & Metabolic Disorders ·(unknown), Khadijeh Mirzaei, Parisa Shabani, (unknown), Solaleh Emamgholipour, (unknown), Bagher Larijani	2
20	Compare the Effect of Eicosapentaenoic Acid, as Supplement Drug and Oxidized Low-Density Lipoprotein as Atherogenic Factor on the Expression of CD36 and Peroxisome Proliferator-Activated Receptor Gamma 1996 ·PubMed ·Hossein Babaahmadi‐Rezaei, Mahmood Doosti, (unknown), Parisa Shabani	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact